List of insiders holdings for OPIANT PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Ki Seijin Director | 2010-03-25 15:32:24 | 0 5,000,000 | 5,000,000 | Form 5 |
Pollack Kevin See Remarks | 2018-10-09 16:05:54 | 148,834 0 | 148,834 | Form 13D |
WOLF GEOFFREY 10% Owner | 2018-04-17 12:11:22 | 124,500 0 | 124,500 | Form 4 |
Mottiwala Aziz Chief Commercial Officer | 2019-09-20 16:06:14 | 50,000 0 | 50,000 | Form 3 |
Thompson Rahsaan General Counsel | 2019-09-20 16:04:51 | 40,000 0 | 40,000 | Form 3 |
Silver Gabrielle Alison Director | 2023-03-03 09:27:04 | 0 0 | 0 | Form 4 |
Belmont Partners LLC Meuse Joseph J 10% Owner | 2009-08-26 09:58:40 | 0 0 | 0 | Form 4 |
Ruth Matthew R. Chief Commercial Officer | 2023-03-03 09:22:53 | 0 0 | 0 | Form 4 |
Daly Richard J Director | 2023-03-03 09:20:53 | 0 0 | 0 | Form 4 |
CRYSTAL ROGER Chief Executive Officer 10% Owner | 2023-03-03 09:18:59 | 0 0 | 0 | Form 4 |
Ellison Mark Jason Heath Chief Development Officer | 2023-03-03 09:16:40 | 0 0 | 0 | Form 4 |
Sinclair Michael Director 10% Owner | 2023-03-03 09:10:52 | 0 0 | 0 | Form 4 |
MacDougall Ann L. Director | 2023-03-03 09:08:29 | 0 0 | 0 | Form 4 |
Lorianne Masuoka K. Director | 2023-03-03 09:05:53 | 0 0 | 0 | Form 4 |
Gorman Brian General Counsel | 2023-03-03 09:03:12 | 0 0 | 0 | Form 4 |
Thomas Thomas T. Director | 2023-03-03 09:00:20 | 0 0 | 0 | Form 4 |
O'Toole David D Chief Financial Officer | 2023-03-03 08:57:07 | 0 0 | 0 | Form 4 |
Collard Craig A Director | 2023-03-03 09:25:03 | 0 0 | 0 | Form 4 |
Skolnick Phil Chief Scientific Officer | 2023-03-03 09:13:19 | 0 0 | 0 | Form 4 |